Precision medicine starts here

Blue Latitude Health|18th May 2018

Precision medicine is set to revolutionise the healthcare sector, promising vastly improved outcomes for patients. However, as treatments become more precise, pharma companies will need to create more targeted commercial strategies. Meanwhile, the clinical trial recruitment process will become more challenging and a new series of stakeholders will emerge. These are just some of the barriers.

That’s why have dedicated the latest edition of our ‘Perspective’ magazine to this complex topic. We have combined the views of our in-house precision medicine experts and voices from key industry leaders to give you the latest information on the trend set to redefine healthcare as we know it – precision medicine.

In this edition of ‘Perspective’, we answer the following questions:

  • Are we ready for precision medicine?
  • How can you master the precision medicine opportunity?
  • How can industry drive greater engagement in the clinical trial recruitment process?
  • Will precision medicine change the way we interact with patients?
  • Who are the new healthcare influencers?

Medical information in precision medicine

Natasha Cowan|14th June 2018

Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine.

 

read more

Is the pharma business model ready for precision medicine?

Fred Bassett|11th June 2018

Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health Co-founder and Head of Strategy Fred Bassett explores the challenges and opportunities while introducing the latest issue of 'Perspective' magazine on this weighty topic.

read more

Behavioural insights to navigate complex healthcare markets

Martine Leroy|6th June 2018

Head of Insight Martine Leroy reveals how her team uses behavioural insights to help develop strong pharma brands and services, which successfully navigate complex situations.

read more